Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria.
Eight strains of probiotic bacteria, including Lactobacillus rhamnosus, Bifidobacterium longum, L. salivarius, L. plantarum, L. acidophilus, L. paracasei, B. lactis type Bl-O4, and B. lactis type Bi-07, were studied for their acid, bile, and heat tolerance. Microencapsulation in alginate matrix was used to enhance survival of the bacteria in acid and bile as well as a brief exposure to heat. Free probiotic organisms were used as a control. The acid tolerance of probiotic organisms was tested using HCl in MRS broth over a 2-h incubation period. Bile tolerance was tested using 2 types of bile salts, oxgall and taurocholic acid, over an 8-h incubation period. Heat tolerance was tested by exposing the probiotic organisms to 65 degrees C for up to 1 h. Results indicated microencapsulated probiotic bacteria survived better (P < 0.05) than free probiotic bacteria in MRS containing HCl. When free probiotic bacteria were exposed to oxgall, viability was reduced by 6.51-log CFU/mL, whereas only 3.36-log CFU/mL was lost in microencapsulated strains. At 30 min of heat treatment, microencapsulated probiotic bacteria survived with an average loss of only 4.17-log CFU/mL, compared to 6.74-log CFU/mL loss with free probiotic bacteria. However, after 1 h of heating both free and microencapsulated probiotic strains showed similar losses in viability. Overall microencapsulation improved the survival of probiotic bacteria when exposed to acidic conditions, bile salts, and mild heat treatment.
Ding
W K
WK
School of Molecular Sciences, Victoria Univ., Werribee Campus, PO Box 14428, Melbourne, Victoria 8001, Australia.
Shah
N P
NP
D000464:Alginates; D000704:Analysis of Variance; D001419:Bacteria / Q000187:drug effects*; D001646:Bile / Q000382:microbiology*; D015169:Colony Count, Microbial; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006358:Hot Temperature; D006851:Hydrochloric Acid / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D050296:Microbial Viability / Q000187:drug effects; D008863:Microspheres; D019936:Probiotics / Q000378:metabolism*; D013696:Temperature; D013997:Time Factors
D000464:Alginates; D006603:Hexuronic Acids; D020723:Glucuronic Acid; D006851:Hydrochloric Acid